Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| IPR | Director Nominations | |||
| IPR | 2025 Annual Report | PRICE SENSITIVE | ||
| IPR | 2025 Preliminary Full Year Result (Unaudited) | PRICE SENSITIVE | ||
| IPR | 2025 Half Year Result and Interim Report | PRICE SENSITIVE | ||
| IPR | 2024 Annual Meeting result | |||
| IPR | 2024 Annual Meeting Presentation Material | PRICE SENSITIVE | ||
| IPR | Notice of 2024 Annual Meeting of Shareholders | |||
| IPR | 2024 Annual Report | PRICE SENSITIVE | ||
| IPR | 2024 Preliminary Full Year Result (Unaudited) | PRICE SENSITIVE | ||
| IPR | 2024 Half Year Result and Interim Report | PRICE SENSITIVE | ||
| IPR Director Nominations | |||
| 12:57 | 122.43KB | ||
| IPR 2025 Annual Report | |||
| 30/06/25 | PRICE SENSITIVE | 590.58KB | |
| IPR 2025 Preliminary Full Year Result (Unaudited) | |||
| 29/05/25 | PRICE SENSITIVE | 223.03KB | |
| IPR 2025 Half Year Result and Interim Report | |||
| 28/11/24 | PRICE SENSITIVE | 152.56KB | |
| IPR 2024 Annual Meeting result | |||
| 30/09/24 | 141.3KB | ||
| IPR 2024 Annual Meeting Presentation Material | |||
| 27/09/24 | PRICE SENSITIVE | 2.74MB | |
| IPR Notice of 2024 Annual Meeting of Shareholders | |||
| 02/09/24 | 71.62KB | ||
| IPR 2024 Annual Report | |||
| 01/07/24 | PRICE SENSITIVE | 531.49KB | |
| IPR 2024 Preliminary Full Year Result (Unaudited) | |||
| 29/05/24 | PRICE SENSITIVE | 771.08KB | |
| IPR 2024 Half Year Result and Interim Report | |||
| 29/11/23 | PRICE SENSITIVE | 268.22KB | |
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| IPR (NZSX) Chart |
Day chart unavailable
